Next Article in Journal
Can Selenium and Molybdenum Restrain Cadmium Toxicity to Pollen Grains in Brassica napus?
Previous Article in Journal
WB1, a Regulator of Endosperm Development in Rice, Is Identified by a Modified MutMap Method
Article

Molecular Mode of Action of Asteriscus graveolens as an Anticancer Agent

1
French Associates Institute for Agriculture and Biotechnology of Drylands, Jacob Blaustein Institutes for Desert Research, Ben-Gurion University of the Negev, 8499000 Midreshet Ben-Gurion, Israel
2
Dead Sea & Arava Science Center, 868215 Sapir, Israel
3
Unit of Aromatic and Medicinal plants, Newe Ya’ar Research Center, ARO 1021, 30095 Ramat-Yishay, Israel
4
National Institute for Biotechnology in the Negev, Ben-Gurion University, 84105 Beer-sheva, Israel
5
Regenerative Medicine & Stem Cell Research Center, Ben-Gurion University of the Negev, 84105 Beer-sheva, Israel
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(8), 2162; https://doi.org/10.3390/ijms19082162
Received: 5 July 2018 / Revised: 18 July 2018 / Accepted: 22 July 2018 / Published: 24 July 2018
(This article belongs to the Section Bioactives and Nutraceuticals)
Asteriscus graveolens (A. graveolens) plants contain among other metabolites, sesquiterpene lactone asteriscunolide isomers (AS). The crude extract and its fractions affected the viability of mouse BS-24-1 lymphoma cells (BS-24-1 cells) with an IC50 of 3 μg/mL. The fraction was cytotoxic to cancer cells but not to non-cancerous cells (human induced pluripotent stem cells); its activity was accompanied by a concentration- and time-dependent appearance of apoptosis as determined by DNA fragmentation and caspase-3 activity. High levels of Reactive Oxygen Species (ROS) were rapidly observed (less than 1 min) after addition of the fraction followed by an increase in caspase-3 activity three hours later. Comparison of RNA-seq transcriptome profiles from pre-and post-treatment of BS-24-1 cells with crude extract of A. graveolens yielded a list of 2293 genes whose expression was significantly affected. This gene set included genes encoding proteins involved in cell cycle arrest, protection against ROS, and activation of the tumor suppressor P53 pathway, supporting the biochemical findings on ROS species-dependent apoptosis induced by A. graveolens fraction. Interestingly, several of the pathways and genes affected by A. graveolens extract are expressed following treatment of human cancer cells with chemotherapy drugs. We suggest, that A. graveolens extracts maybe further developed into selective chemotherapy. View Full-Text
Keywords: sesquiterpene lactones; apoptosis; caspases; DNA fragmentation; reactive oxygen species; RNA-Seq sesquiterpene lactones; apoptosis; caspases; DNA fragmentation; reactive oxygen species; RNA-Seq
Show Figures

Graphical abstract

MDPI and ACS Style

Tayeh, Z.; Dudai, N.; Schechter, A.; Chalifa-Caspi, V.; Barak, S.; Ofir, R. Molecular Mode of Action of Asteriscus graveolens as an Anticancer Agent. Int. J. Mol. Sci. 2018, 19, 2162. https://doi.org/10.3390/ijms19082162

AMA Style

Tayeh Z, Dudai N, Schechter A, Chalifa-Caspi V, Barak S, Ofir R. Molecular Mode of Action of Asteriscus graveolens as an Anticancer Agent. International Journal of Molecular Sciences. 2018; 19(8):2162. https://doi.org/10.3390/ijms19082162

Chicago/Turabian Style

Tayeh, Zainab, Nativ Dudai, Alona Schechter, Vered Chalifa-Caspi, Simon Barak, and Rivka Ofir. 2018. "Molecular Mode of Action of Asteriscus graveolens as an Anticancer Agent" International Journal of Molecular Sciences 19, no. 8: 2162. https://doi.org/10.3390/ijms19082162

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop